René Marcel De Jong

This inventor holds 10 USPTO granted patents and 11 published patent applications and 15 EPO patents. Top assignee: Dsm IP Assets B.v.. Active years: 2018-2026.

USPTO Granted Patents = 10 (Patent Applications = 11)

% Patents Active = 90.0

EPO Patents = 15 (Patent Applications = 29)

Average Co-Inventor Count = 3.7

ph-index = 1

Company Filing History:

10 out of 1,775

Dsm IP Assets B.v.

patents

Years Active: 2018-2026

Loading Chart...

10 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12735672 - SACCHAROMYCES YEAST CELL AND FERMENTATION PROCESS USING SUCH (2026-09-15),

2. 12662661 - NOVEL ACETYL-TRANSFERASES (2026-06-23),

3. 12195769 - Lipolytic enzyme variants (2025-01-14),

4. 12091436 - Steviol glycoside transport (2024-09-17),

5. 11944104 - Variant maltogenic alpha-amylase (2024-04-02),

6. 11608364 - Steviol glycoside transport (2023-03-21),

7. 10612013 - Enzyme variants (2020-04-07),

8. 10487125 - Ice structuring protein (2019-11-26),

9. 9994837 - Enzyme variants (2018-06-12),

10. 9944905 - Fumarate reductases (2018-04-17),

Title: Innovations of René Marcel De Jong

Introduction

René Marcel De Jong is a notable inventor based in Echt, Netherlands. He has made significant contributions to the field of biotechnology, particularly in the development of enzyme variants. With a total of 10 patents to his name, De Jong's work has had a considerable impact on various industrial applications.

Latest Patents

One of his latest patents is focused on novel acetyl-transferases, specifically lipolytic enzyme variants. This invention relates to a variant polypeptide that exhibits lipase activity. The polypeptide has an amino acid sequence with at least 70% identity to a mature amino acid sequence of SEQ ID NO: 1 or SEQ ID NO: 6. Notably, the polypeptide includes an amino acid substitution at position 295 and at least one further amino acid substitution at positions 113, 121, 179, and/or 284. These positions are defined with reference to SEQ ID NO: 1 or SEQ ID NO: 6. The invention also encompasses a process for preparing dough using the disclosed polypeptide, leading to baked products derived from the dough.

Career Highlights

De Jong is currently associated with DSM IP Assets B.V., a company known for its focus on innovation in health, nutrition, and materials. His work at DSM has allowed him to explore and develop cutting-edge technologies in enzyme applications.

Collaborations

Throughout his career, De Jong has collaborated with several talented individuals, including Petrus Jacobus Theodorus Dekker and Joke Anneleen Putseys. These collaborations have further enriched his research and development efforts.

Conclusion

René Marcel De Jong's contributions to the field of biotechnology through his innovative patents and collaborations highlight his role as a significant inventor. His work continues to influence the industry and pave the way for future advancements.